横条 发表于 2025-3-25 04:02:34

http://reply.papertrans.cn/3/228/22748/22748-21.png

Ceramic 发表于 2025-3-25 08:48:01

Submitted on: 18 July 2003.
Revised on: 25 July 2003.
Accepted on: 19 August 2003.
Nature Reviews Clinical Oncology

Consensus 发表于 2025-3-25 13:29:04

http://reply.papertrans.cn/3/228/22748/22748-23.png

configuration 发表于 2025-3-25 18:33:04

http://reply.papertrans.cn/3/228/22748/22748-24.png

扩大 发表于 2025-3-25 21:27:51

http://reply.papertrans.cn/3/228/22748/22748-25.png

glucagon 发表于 2025-3-26 03:17:38

http://reply.papertrans.cn/3/228/22748/22748-26.png

抗原 发表于 2025-3-26 07:35:00

http://reply.papertrans.cn/3/228/22748/22748-27.png

MUMP 发表于 2025-3-26 09:11:19

Submitted on: 03 August 2020.
Revised on: 02 September 2020.
Accepted on: 30 September 2020.
Nature Reviews Clinical Oncology

名义上 发表于 2025-3-26 15:38:50

Submitted on: 05 May 2018.
Revised on: 22 May 2018.
Accepted on: 02 June 2018.
Nature Reviews Clinical Oncology

的是兄弟 发表于 2025-3-26 19:42:58

http://reply.papertrans.cn/3/228/22748/22748-30.png
页: 1 2 [3] 4
查看完整版本: SCIE期刊Nature Reviews Clinical Oncology 2024/2025影响因子:81.145 (NAT REV CLIN ONCOL) (1759-4774). (ONCOLOGY)(肿瘤学)Science Ci